Detalhe da pesquisa
1.
IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing.
Proc Natl Acad Sci U S A
; 120(21): e2221116120, 2023 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192158
2.
Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.
Proc Natl Acad Sci U S A
; 117(10): 5269-5279, 2020 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32086391